Ambroxol as a Disease-modifying Treatment in GBA-PD

Clinical trial NCT05287503 · COMPLETED

Trial details

NCT number: NCT05287503
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease GBA Gene Mutation

Start date: 2022-03-09
Primary completion: 2024-12-15
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.